Federal Register of Legislation - Australian Government

Skip to primary navigation Skip to primary content
Federal Register of Legislation Skip to Content
SearchOpen search

Primary content

Bookmark

this version | go to latest

National Health Act 1953 - Amendment determination under paragraph 98C(1)(b) - conditions (No. PB 73 of 2010)

Authoritative Version
  • - F2010L02067
  • No longer in force
PB 73 of 2010 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide for changes to the conditions subject to which payments will be made by the Commonwealth in respect of supply of pharmaceutical benefits by approved pharmacists and medical practitioners.
Administered by: Health
Registered 19 Jul 2010
Tabling HistoryDate
Tabled HR28-Sep-2010
Tabled Senate28-Sep-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 73 of 2010

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 5 JULY 2010

 

 

 

 

 

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 August 2010.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.

Schedule 1            Amendments

 

[1]      Schedule 4, after item dealing with Brinzolamide

insert in the columns in the order indicated:

 

Brinzolamide with Timolol

Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL

[2]      Schedule 4, after item dealing with Glucose Indicator—Blood in the form
Test strips, 100 (Accu-Chek Active)

insert in the column headed “Form (strength, type, size, etc.)”:

 

 

Test strips, 100 (Accu-Chek Advantage/Sensor Comfort)

[3]      Schedule 4, item dealing with Macrogol 3350

insert as first entry in the column headed “Form (strength, type, size, etc.)”:

 

 

Powder for oral solution 510 g